Recombinant Human LGALS3 Protein (Ala2-Ile250)
Product Description
Cat
IMP-9913
Official Symbol
LGALS3
Product Overview
Recombinant human Galectin-3 protein (Ala2-Ile250) without tag was expressed in Human embryonic kidney cell.
Description
This gene encodes a member of the galectin family of carbohydrate binding proteins. Members of this protein family have an affinity for beta-galactosides. The encoded protein is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. This protein can self-associate through the N-terminal domain allowing it to bind to multivalent saccharide ligands. This protein localizes to the extracellular matrix, the cytoplasm and the nucleus. This protein plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation. The protein exhibits antimicrobial activity against bacteria and fungi. Alternate splicing results in multiple transcript variants.
Expression System
HEK293
Species
Human
Tag
Tag Free
Predicted N Terminal
No results obtained: Ala2 predicted.
Form
Lyophilized from a 0.2 μm filtered solution in HEPES, NaCl, TCEP, PEG and Trehalose.
Molecular Mass
Predicted Molecular Mass: 25 kDa
SDS-PAGE: 26-31 kDa, reducing conditions
Protein length
Ala2-Ile250
Bio-activity
Measured by its ability to support the adhesion of MOLT-4 human acute lymphoblastic leukemia cells. The ED50 for this effect id 0.6-3 μg/mL. Measured by its ability to agglutinate human red blood cells. Hadari, Y.R. et al. (2000) J. Cell Sci. 113:2385. The ED50 for this effect is 3-10 μg/mL.
Endotoxin
<0.10 EU/μg of the protein by the LAL method.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
Reconstitution
Reconstitute at 100 μg/mL in PBS.
SDS-PAGE
SDS-PAGE

Bioactivity-ELISA 1
Bioactivity

Measured by its ability to support the adhesion of MOLT-4 human acute lymphoblastic leukemia cells. The ED50 for this effect id 0.6-3 μg/mL. Measured by its ability to agglutinate human red blood cells. Hadari, Y.R. et al. (2000) J. Cell Sci. 113:2385. The ED50 for this effect is 3-10 μg/mL.

Data Sheet MSDS
For research or industrial raw materials, not for personal medical use!

Online Inquiry
Contact Info